Innocoll
is a New Jersey-based biotech pharmaceutical company that researches and develops collagen-infused medicinal products for postsurgical pain management... Read moreInnocoll
is a New Jersey-based biotech pharmaceutical company that researches and develops collagen-infused medicinal products for postsurgical pain management... Read more
News
Sep 27, 2022
Pharmabiz
Innocoll: Innocoll, DURECT launch Posimir in US to treat postsurgical pain following arthroscopic subacromial decompression surgery
Jul 06, 2022
FinanzNachrichten
Innocoll: Innocoll Pharmaceuticals Limited: Innocoll Announces Publication of Positive Results from Pivotal Clinical Trial of POSIMIR in Arthroscopic Subacromial Decompression
Mar 02, 2022
FinanzNachrichten
Innocoll: Innocoll Pharmaceuticals Limited: Innocoll Announces Positive Topline Results For XARACOLL (bupivacaine hydrochloride) implant in a Phase 3 Study to Support Expanded Use
Feb 08, 2022
Global Legal Chronicle
Innocoll: Innocoll Biotherapeutics' $125 Million Term Loan Facility
Jan 31, 2022
ABF Journal
Innocoll: Oaktree Capital management Provides Debt Refinancing to Innocoll
Jan 28, 2022
FirstWord Pharma
Innocoll: Innocoll Announces Successful Completion of Debt Refinancing
Dec 22, 2021
MarketScreener
Innocoll: DURECT : and Innocoll Announce a $136 Million U.S. Licensing Agreement for POSIMIR (Bupivacaine Solution) - Form 8-K
Dec 10, 2021
Real Estate Weekly
Innocoll: Biotech co opens new US HQ in princeton
Apr 14, 2021
Drug Delivery Business
Innocoll: Innocoll Biotherapeutics initiates Phase 3 trials for collagen drug-device
Jan 11, 2021
Boston Citybizlist
Innocoll: Innocoll Appoints Louis Pascarella as CEO
